Aarti Drugs fundamental analysis
AARTIDRUGS
393.65
7.00 (1.81%)Last updated on 13 Jan, 2026 | 15:31 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Aarti Drugs Fundamentals
P/E Ratio
17.65
P/B Ratio
2.39
Div. Yield
0.26
Sector P/E
69.98
Sector P/B
0.94
Sec. Div. Yield
0.57
Aarti Drugs Fundamentals is currently trading with a P/E Ratio of 17.65, compared to the sector average of 69.98. Its P/B Ratio stands at 2.39, while the sector’s is 0.94. In terms of returns, the stock offers a Dividend Yield of 0.26%, which is than the sector’s 0.57%.
Aarti Drugs Score Card
Price
Attractive
Growth
Moderate
Quality
Average
Management
Good
On its scorecard, Aarti Drugs reflects: Price – Attractive, Growth – Moderate, Quality – Average, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
